Even when patients are treated with targeted cancer therapies, many lung cancer patients suffer a recurrence. Researchers at Cold Spring Harbor Laboratory wanted to uncover how some cancers escape the power of targeted treatment. Their work was published in the journal eLife this week.
The team of scientists, lead by Raffaella Sordella, found that a tiny subset of cells in or around a cancerous tumor can change over time and become the seeds of a killer relapse.
Get the full story at our sister site, Drug Delivery Business News.
The post Study: Why even targeted lung cancer therapies eventually fail appeared first on MassDevice.
from MassDevice http://ift.tt/2nQ2h4f
Cap comentari:
Publica un comentari a l'entrada